Menopause Hormone Therapy Is Making a Comeback. What Women Should Know

For millions of American women, menopause can bring more than occasional hot flashes. Sleepless nights, sudden changes in body temperature, vaginal discomfort, and disruptions to everyday life can make this natural transition surprisingly difficult.

Now, a treatment that many women were once discouraged from using is receiving renewed attention.

Menopausal hormone therapy, which uses estrogen alone or combined with a progestogen, is increasingly being reconsidered by doctors and patients as researchers develop a clearer understanding of its benefits and risks.

In an August NPR report, family physician Dr. Mara Gordon examined how medical thinking has changed since early studies raised serious concerns about hormone therapy more than two decades ago.

The emerging evidence offers an important message: for many otherwise healthy women in their late 40s and 50s, hormone therapy can provide substantial symptom relief, particularly when treatment begins near the onset of menopause.

The larger question involves whether these treatments could offer benefits beyond symptom management, especially for cardiovascular health.

Why Doctors Stopped Prescribing Hormones

For years, hormone therapy was commonly prescribed to help women manage symptoms associated with declining estrogen levels.

That changed dramatically in 2002.

Early findings from the Women's Health Initiative, a major federal research program involving thousands of women, associated certain hormone treatments with increased risks of breast cancer, blood clots, stroke, and cardiovascular problems.

The results transformed medical practice.

According to figures highlighted by NPR, approximately 22% of American women over 40 were receiving menopausal hormone therapy in 1999–2000. By 2010, that proportion had fallen to approximately 5%.

For many women, the message was straightforward: hormones were potentially dangerous and should generally be avoided.

But subsequent research revealed that the picture was more complicated.

Scientists began examining differences in age, treatment formulation, medical history, and how long women had been experiencing menopause.

One particularly important finding involved when treatment begins.

The Timing of Treatment Can Change the Equation

Medical researchers increasingly recognize that hormone therapy does not carry identical risks for every woman.

The Menopause Society's clinical guidance identifies an important window: women younger than 60 or within approximately ten years of menopause onset.

For otherwise healthy women without major contraindications, the benefits of hormone therapy during this period generally outweigh the risks when treating bothersome menopause symptoms.

The situation can be different for women who begin treatment after 60 or more than ten years after menopause.

Their risks of cardiovascular disease, stroke, and blood clots may be greater.

This helps explain why studies conducted in different age groups have sometimes reached different conclusions.

A woman beginning treatment at 51 for severe night sweats is not necessarily facing the same medical considerations as someone beginning systemic hormone therapy at 72.

The important development is a shift away from treating all women as though their medical circumstances were identical.

Researchers are increasingly emphasizing individualized decisions based on age, symptoms, cardiovascular risk, personal history, and treatment options.

Could Hormone Therapy Protect the Heart?

One of the most intriguing questions involves cardiovascular health.

Heart disease remains the leading cause of death among women in the United States.

During menopause, declining estrogen levels occur alongside changes in cholesterol, body fat distribution, blood vessels, and other factors influencing cardiovascular risk.

Some research suggests that estrogen therapy initiated closer to menopause may have favorable effects on certain cardiovascular measures.

Dr. Karen Adams, a Stanford University professor interviewed by NPR, explained that scientists are still investigating whether early hormone therapy might help protect against atherosclerosis and related heart conditions.

Studies examining the timing of treatment have generated encouraging findings, although the evidence has not established that prescribing hormone therapy specifically to prevent heart attacks improves long-term outcomes.

The American College of Obstetricians and Gynecologists continues to advise against using combined hormone therapy solely to prevent heart disease.

That distinction matters.

A treatment can be appropriate for managing severe menopause symptoms even when its ability to prevent cardiovascular disease remains uncertain.

For heart protection, established measures such as managing blood pressure, controlling cholesterol, exercising, and avoiding smoking remain essential.

The Type of Hormone Therapy Matters Too

Another important advancement involves understanding differences between hormone formulations.

Hormone therapy can be delivered through pills, skin patches, gels, sprays, and vaginal treatments.

These methods do not all work in exactly the same way.

Oral estrogen passes through the digestive system and liver, influencing certain proteins involved in blood clotting.

Transdermal estrogen, delivered through the skin, avoids much of this first-pass liver processing.

Research suggests that transdermal treatment may carry a lower risk of venous blood clots than oral estrogen.

Women who still have a uterus generally require a progestogen alongside systemic estrogen to protect against endometrial cancer.

Women who have undergone a hysterectomy may be able to use estrogen alone.

Low-dose vaginal estrogen is another option, especially for vaginal dryness and certain urinary symptoms. Because relatively little reaches the bloodstream, its risk profile differs from systemic therapy.

These differences give healthcare professionals more opportunities to tailor treatment to individual needs.

The Benefits Extend Beyond Hot Flashes

For women experiencing significant menopause symptoms, effective treatment can improve daily life.

Hormone therapy remains the most effective treatment for hot flashes and night sweats, according to The Menopause Society.

Reducing those symptoms may improve sleep, daytime comfort, and the ability to maintain normal activities.

Systemic estrogen also helps prevent bone loss and reduces fracture risk, an important consideration because declining estrogen contributes to osteoporosis after menopause.

For a woman balancing work, family responsibilities, and her own health, better symptom control can make a meaningful difference.

Yet hormone therapy is not appropriate for everyone.

Women with histories of certain cancers, blood clots, stroke, heart attacks, or liver disease may face greater risks. Nonhormonal medications and other treatments are available for women who cannot or prefer not to use hormones.

The goal is to offer treatment choices grounded in individual medical circumstances rather than blanket assumptions.

What Women Should Ask Their Doctors

The renewed discussion surrounding hormone therapy creates an opportunity for more informed conversations about menopause.

Women experiencing disruptive symptoms can discuss how their age, medical history, and time since menopause affect their treatment options.

They can also ask whether oral or transdermal estrogen would be more suitable, whether progesterone is needed, and what alternatives exist.

A cardiovascular risk assessment may be particularly useful for women with hypertension, diabetes, elevated cholesterol, or a family history of heart disease.

Treatment should be reviewed periodically as symptoms and health circumstances change.

Women should also be cautious about online marketing portraying hormones as guaranteed solutions for aging, weight gain, or longevity.

A treatment's proven benefits are more meaningful than promises unsupported by clinical evidence.

A New Chapter in Women's Healthcare

The changing conversation around menopause represents an important development in women's health.

For years, many women faced difficult symptoms while receiving limited guidance about treatment options.

Today, a growing body of research is helping clinicians distinguish which patients are most likely to benefit, how treatment can be personalized, and which risks require closer attention.

Newer evidence has not established hormone therapy as a universal anti-aging treatment. It has helped restore a valuable medical option for many women who need symptom relief.

And research into estrogen's relationship with the cardiovascular system may eventually answer questions that remain unresolved.

The broader lesson is that women's healthcare improves when scientific evidence replaces assumptions and patients receive information suited to their individual needs.

Menopause should not mean accepting years of unnecessary discomfort. With better research, informed medical guidance, and personalized treatment, women have more opportunities to protect their health and maintain their quality of life through every stage of aging.